Palbociclib has no clinically relevant effect on the QTc interval in patients with advanced breast cancer.

by Durairaj, Chandrasekar, Ruiz-Garcia, Ana, Gauthier, Eric R, Huang, Xin, Lu, Dongrui R, Hoffman, Justin T, Finn, Richard S, Joy, Anil A, Ettl, Johannes, Rugo, Hope S, Zheng, Jenny, Wilner, Keith D, Wang, Diane D
Published 2018

Phase II study of sunitinib as second-line treatment for advanced gastric cancer

by Bang, Yung-Jue, Kang, Yoon-Koo, Kang, Won K., Boku, Narikazu, Chung, Hyun C., Chen, Jen-Shi, Doi, Toshihiko, Sun, Yan, Shen, Lin, Qin, Shukui, Ng, Wai-Tong, Tursi, Jennifer M., Lechuga, Maria J., Lu, Dongrui Ray, Ruiz-Garcia, Ana, Sobrero, Alberto
Published 2021